FDA Approval Activities for this Drug…

Rifampin Capsules USP,150 mg & 300 mg/vial, VersaPharm ANDA 65-028 3/14/01 3/30/01 Rifampin for Injection USP, 600 mg/vial, Bedford ANDA 64-217 ISONIAZID; PYRAZINAMIDE; RIFAMPIN Tablet; 50MG;300MG;120MG RIFATER AVENTIS 061884 ISONIAZID; RIFAMPIN Capsule; 150MG;300MG RIFAMATE AVENTIS 062303 RIFAMPIN Capsule; 150MG RIFADIN AVENTIS 050420 RIFAMPIN Capsule; 300MG RIFADIN AVENTIS 064150 RIFAMPIN Capsule; 150MG RIFAMPIN Eon 064150 RIFAMPIN Capsule; 300MG RIFAMPIN Eon 050429 RIFAMPIN Capsule; 300MG RIMACTANE Geneva 065028 RIFAMPIN Capsule; 150MG RIFAMPIN VERSAPHARM 065028 RIFAMPIN Capsule; 300MG RIFAMPIN VERSAPHARM 050627 RIFAMPIN Injection 600MG/VIAL RIFADIN AVENTIS 064217 RIFAMPIN Injection 600MG/VIAL RIFAMPIN Bedford RIFADIN (rifampin capsules USP), Aventis Pharmaceuticals, Labeling Revision RIFADIN (rifampin for injection USP) IV, Aventis Pharmaceuticals, Labeling Revision | Rifampin Capsules, Sandoz, Inc., Labeling Revision | Rifater (rifampin, isoniazid and pyrazinamide) Tablets, Aventis Pharma, Labeling Revision

For the latest approval information and links for this API, please see the main page.